Project data

• IATI IdentifierXM-DAC-6-4-012350-01-1
• AID012350/01/1
• CRS Activity identifier2022000093
• Planned start 2022/03/31
• Planned End 2022/12/31
• Actual start 2022/06/17
• Actual end 2023/02/13
• Bi/Multilateral Bilateral
• Status Closed
• Tied status Untied

Sectors

• 12250 - Infectious disease control 100.0%

Policy markers

• Gender Equality not targeted
• Disaster Risk Reduction(DRR) not targeted
• Nutrition not targeted
• Aid to Environment not targeted
• Participatory Development/Good Governance not targeted
• Trade Development not targeted
• Aid Targeting the Objectives of the Convention on Biological Diversity not targeted
• Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation not targeted
• Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation not targeted
• Aid Targeting the Objectives of the Convention to Combat Desertification not targeted

SDGs

• 17.16 - Enhance the Global Partnership for Sustainable Development, complemented by multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources, to support the achievement of the Sustainable Development Goals in all countries, in particular developing countries
• 17.17 - Encourage and promote effective public, public-private and civil society partnerships, building on the experience and resourcing strategies of partnerships
• 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
• 3.8 - Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
• 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
• 3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks